Genmab A/S $320.00 (+9.37, 3.02%)

Buy or Sell Report US

Analysis for Genmab A/S

Summary
LONGBUY: Best moves 24 which gains 755.65, return on capital invested 2.4%
Details
Systematic Stock Control...Version 3.1.2.18095: x64 MS Windows
Copyright© Graham Armstrong, 1997, 2003, 2021-2026

Report file for: Genmab A/S
Published on: 17 August 2026 22:31:15 -06:00

                                 Raw Data Range

  Hi-Low         First          Last        Lowest       Highest
     252      232.3000      320.0000      232.3000      352.0000

                       Hi-Low Time taken: 00:00.0000055

===============================================================================
                               Maximum Reduction

               Polynomials 2, Moves 1, Sigma 7.1977, Reduction 93

                              Buy or Sell Summary

    Move     Alpha    Sigma    Investment      Return     Mean    Percent    Periods
       1    100.00     0.00             0           0     0.00       0.00          0
       2     66.67    18.38      33859.54     -174.45    -1.50      -0.52        116
       3     50.00     2.97      33381.37     -190.46    -1.66      -0.57        115
       4     40.00     0.81      33141.51      322.58     2.81       0.97        115
       5     33.33     0.45      34251.12      -81.29    -0.69      -0.24        118
       6     28.57     0.34      37572.76     -204.02    -1.58      -0.54        129
       7     25.00     0.33      42933.46      312.95     2.11       0.73        148
       8     22.22     0.36      47865.75       24.56     0.15       0.05        166
       9     20.00     0.38      47885.13     -130.45    -0.79      -0.27        166
      10     18.18     0.38      41788.17     -220.15    -1.54      -0.53        143
      11     16.67     0.36      39079.32     -737.74    -5.46      -1.89        135
      12     15.38     0.32      36248.56     -524.83    -4.20      -1.45        125
      13     14.29     0.27      36301.15     -595.16    -4.72      -1.64        126
      14     13.33     0.23      38720.98     -341.61    -2.55      -0.88        134
      15     12.50     0.20      37946.14     -771.31    -5.89      -2.03        131
      16     11.76     0.17      36720.63     -877.32    -6.96      -2.39        126
      17     11.11     0.15       36984.4    -1225.87    -9.65      -3.31        127
      18     10.53     0.13      37724.94     -386.72    -3.02      -1.03        128
      19     10.00     0.12      33045.19     -213.87    -1.89      -0.65        113
      20      9.52     0.12      29909.34     -248.64    -2.41      -0.83        103
      21      9.09     0.11      33283.13      620.32     5.39       1.86        115
      22      8.70     0.11      35753.14      661.18     5.33       1.85        124
      23      8.33     0.12      30692.77      656.65     6.19       2.14        106
      24      8.00     0.12         31491      755.65     6.93       2.40        109
      25      7.69     0.12      35096.81     -318.68    -2.55      -0.91        125

   LONGBUY: Best moves 24 which gains 755.65, return on capital invested 2.4%

  Guidance is to LONGBUY, Last Effect 320, minimum underlying current price 10

    Guidance is to LONGBUY, Average Return 6.93%, minimum average return 5%

Guidance is to LONGBUY, Invested Percentage 43.25%, minimum invested periods percentage 30%

                      Overall Time taken: 00:00.0227030


/...End of report

Casting Forward Corporation, trading as Scientific Decisions Consultants
Address: 1322 18 Avenue Northwest, Calgary, Alberta T2M 0W4, Canada
Telephone: +1 (587) 885 3191
Email: shares@scidec.net
Website: https://ssc.castfwd.com/
GNMSF @ US Analysis 52*